Alphabet unit halts glucose-detecting contact lens project

Alphabet unit halts glucose-detecting contact lens project

  • November 18, 2018
Table of Contents

Alphabet unit halts glucose-detecting contact lens project

Alphabet Inc’s life sciences division Verily said on Friday that it was putting on hold one of its oldest and highest-profile projects, a smart contact lens designed to help monitor sugar levels. The project, started in 2014, aimed to help diabetics better manage their blood sugar levels by embedding sensors on a contact lens to monitor the glucose levels in their tears. In a blog update, Verily cited here insufficient consistency in the correlation between tear glucose and blood glucose concentrations to support the requirements of a medical device.

Verily, which was previously part of the tech firm’s Google X research and development unit, had partnered with Novartis’ eye-care division, Alcon, to develop the lens.

Source: reuters.com

Share :
comments powered by Disqus

Related Posts

‘Spectacular’ diabetes treatment could end daily insulin injections

‘Spectacular’ diabetes treatment could end daily insulin injections

A potential medical breakthrough that could put an end to the daily insulin injections endured by people living with diabetes has been unveiled by Dutch scientists. By destroying the mucous membrane in the small intestine and causing a new one to develop, scientists stabilised the blood sugar levels of people with type 2 diabetes. The results have been described as “spectacular” – albeit unexpected – by the chief researchers involved.

Read More
A cure for cancer: how to kill a killer

A cure for cancer: how to kill a killer

Last month, the Nobel prize in medicine was awarded for two breakthrough scientific discoveries heralded as having “revolutionised cancer treatment”, and “fundamentally changed the way we view how cancer can be managed”. One of them went to a charismatic, harmonica-playing Texan named Jim Allison for his breakthrough advances in cancer immunotherapy. His discovery had resulted in transformative outcomes for cancer patients and a radical new direction for cancer research.

Read More